Sugemalimab plus chemotherapy versus chemotherapy for advanced gastric cancer in China: a cost-effectiveness analysis
Abstract This study aimed to evaluate the cost-effectiveness of sugemalimab plus chemotherapy compared to chemotherapy in the treatment of advanced gastric cancer in China. A Markov model of partitioned survival was developed based on the GEMSTONE-303 Phase III clinical trial evaluating sugemalimab...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2025-09-01
|
| coleção: | Scientific Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1038/s41598-025-18030-w |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|